Viewing Study NCT01495351


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT01495351
Status: COMPLETED
Last Update Posted: 2017-09-25
First Post: 2011-11-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma
Sponsor: AHS Cancer Control Alberta
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-10
Start Date Type: ACTUAL
Primary Completion Date: 2015-02
Primary Completion Date Type: ACTUAL
Completion Date: 2015-02-10
Completion Date Type: ACTUAL
First Submit Date: 2011-11-16
First Submit QC Date: None
Study First Post Date: 2011-12-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-09-21
Last Update Post Date: 2017-09-25
Last Update Post Date Type: ACTUAL